| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |